Bringing Expertise Together to Advance the Art of Beauty

On March 10, 2026, the Clinical Exchange on Recombinant Collagen Freeze-Dried Fibers, hosted by Novi Orea, was successfully held at Hilton Garden Inn in Yunlong District, Xuzhou.

The event brought together medical-aesthetics clinicians from Xuzhou and surrounding areas for in-depth discussions on product characteristics, injection techniques, and combination-treatment strategies for recombinant collagen freeze-dried fibers, creating a focused and high-quality academic forum.

01

Advancing Active Regeneration and Clinical Value

Supported by more than a decade of experience in the R&D, manufacturing, registration, and approval of biologic products, Novi Orea’s Recombinant Collagen Freeze-Dried Fibers have attracted broad attention and recognition from clinical experts since launch. Their humanized type III collagen features an active triple-helix structure and strong tissue-regeneration capabilities.

By combining scientific theory with clinical cases, the exchange aimed to standardize clinical procedures and support high-quality development across the medical-aesthetics industry.

02

Two Clinical Directors Share Practical Expertise

Director Yang Dongxu: From Product Characteristics to Full-Layer Anti-Aging Strategies

Yang Dongxu, Technical Director of Baixin Ruiyuan Group and an expert in full-layer anti-aging injections, presented “Product Characteristics and Clinical Application Techniques for Recombinant Collagen Freeze-Dried Fibers.” He systematically reviewed the core advantages of humanized type III collagen, noting that type III collagen accounts for as much as 60% of collagen in infant skin but only about 20% in adult skin, and that its structural decline is an important factor in skin aging.

Novi Orea freeze-dried fibers rebuild the skin microenvironment through an active collagen fiber network, supporting “active regeneration” rather than conventional “inflammation-driven regeneration.” This provides distinctive value for improving skin quality, reducing fine lines, and repairing the barrier. Director Yang also discussed combination-treatment strategies integrating ligament support and nourishment with techniques such as liquid thread lifting and five-layer anchoring.

Director Shi Liyang: Practical Insights Through Detailed Case Analysis

Shi Liyang, Technical Director of Nanjing Weiguang Zhiyan and a physician licensed in both plastic surgery and dermatology, presented “Typical Case Studies and Experience Sharing for Recombinant Collagen Freeze-Dried Fibers.” Beginning with the relationship between collagen and aging, he emphasized that direct supplementation with exogenous type III collagen is an important complement to current rejuvenation treatments. Through before-and-after comparisons from multiple clinical cases, Director Shi demonstrated notable outcomes in periocular anti-aging, facial rejuvenation, and sensitive-skin repair, including reduced fine lines around the eyes, brighter skin tone, improved underlying inflammation, and increased skin thickness. Detailed data and images gave attendees a clear view of the product’s clinical value. He also explained injection depth, dosage ratios, and post-procedure care, providing practical reference for clinical use.

03

In-Depth Exchange on the Frontiers of Clinical Technology

Although the event did not include live demonstrations, the two experts used carefully prepared presentations to systematically review a wide range of clinical cases involving different skin types and indications. Their step-by-step analysis—from treatment rationale to outcome attribution—provided attending physicians with clear, reusable clinical reference cases.

During the technical exchange, attending physicians actively raised questions on injection techniques, combination protocols, and adverse-reaction prevention. The two directors responded in detail, creating a highly interactive discussion.

Participants noted that the small-group, in-depth format enabled more thorough discussion and delivered value beyond their expectations.

Academic Leadership, A Promising Future

The successful event not only created a high-level academic exchange platform for regional medical-aesthetics physicians, but also further supported the standardized clinical application of recombinant collagen freeze-dried fibers.

As a platform-level medical-device brand integrating R&D, manufacturing, and sales in innovative medical-aesthetic ingredients and products, Novi Orea consistently places academic development first. Going forward, the brand will continue to work with industry experts on academic roadshows and clinical seminars, bringing the concepts and technologies of active regeneration to more clinicians and supporting high-quality development across the medical-aesthetics industry.